Baxter International Faces Class Action Lawsuit Over Novum Pump Malfunctions and Investor Concerns
- Baxter International faces a class action lawsuit over alleged undisclosed malfunctions in its Novum Large Volume Pump.
- Allegations include systemic defects, risking patient safety through issues like underinfusion and non-delivery of fluids.
- The lawsuit impacts Baxter's reputation and may influence future regulations on medical device safety and disclosures.
Baxter International Faces Class Action Lawsuit Over Alleged Device Malfunctions
Baxter International, Inc. is currently navigating significant legal challenges as Glancy Prongay & Murray LLP announces a securities fraud class action lawsuit that targets the company. This lawsuit stems from allegations that Baxter failed to properly disclose critical issues with its Novum Large Volume Pump (LVP) between February 23, 2022, and July 30, 2025. The allegations highlight systemic defects in the Novum LVP, which have been linked to malfunctions including underinfusion, overinfusion, and complete non-delivery of fluids. Such failures pose serious risks to patient safety, potentially leading to severe injuries or fatalities.
The allegations suggest that Baxter was aware of numerous malfunctions and injuries associated with the Novum LVP but did not take adequate action to rectify the situation. Instead, the company reportedly issued insufficient customer alerts regarding the device issues. This lack of transparency and action raises serious concerns about Baxter's commitment to patient safety and quality assurance in its medical devices. As a result, there is a growing fear among investors that customers may withdraw existing Novum LVPs from use and cease new purchases, which would directly contradict the positive statements Baxter has made about its business operations and future prospects.
Investors affected by the alleged malpractices now have an opportunity to join the class action lawsuit, but they must act before the lead plaintiff deadline of December 15, 2025. Those interested in participating can reach out to Glancy Prongay & Murray LLP for more information. While potential class members are encouraged to consider their options, they are not required to take immediate action, as they can choose to retain counsel or remain uninvolved. This lawsuit underscores the critical importance of corporate responsibility and transparency, especially in the healthcare sector, where patient safety is paramount.
In addition to the ongoing legal proceedings, Baxter International's reputation could be at stake as the company faces scrutiny from both regulators and the public. The outcome of this lawsuit may not only impact the financial standing of Baxter but could also influence future regulations governing medical device disclosures and safety standards. Stakeholders are closely monitoring developments, as the implications of these allegations could resonate throughout the healthcare industry.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

